NCT05883293 Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary Fibrosis Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05747508 A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis Status UNKNOWN Phase PHASE2
NCT05740475 A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05719038 Diagnostic and Prognostic Model of Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study Status UNKNOWN Phase N/A
NCT05711290 Oxygen Nanobubble Drink Impact on Exercise in Pulmonary Fibrosis Status COMPLETED Phase NA
NCT05670587 A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device Status COMPLETED Phase NA
NCT05387239 Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19 Status SUSPENDED Phase PHASE2
NCT05356052 Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis Status AVAILABLE Phase N/A
NCT05331300 A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease Status COMPLETED Phase PHASE1/PHASE2
NCT05330312 Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF Status COMPLETED Phase NA
NCT05299333 Comparison of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Post Covid Fibrosis Status COMPLETED Phase NA